Baltimore Launches Online Dashboard to Track $600 Million Opioid Restitution Fund Spending

Baltimore has become one of the first major American cities to launch a comprehensive public dashboard tracking how it spends opioid settlement funds, releasing both an interactive online tool and its first annual report on the nearly $600 million the city secured from litigation against pharmaceutical manufacturers and distributors.

Mayor Brandon Scott announced the new transparency measures on April 21, 2026, emphasizing that residents can now follow exactly how dollars obtained from companies that helped fuel the addiction crisis are being reinvested into community healing. The dashboard, which will be updated quarterly, details every allocation made to date alongside the organizations receiving support and the specific services being funded.

From Courtroom to Community

Baltimore's opioid restitution fund represents one of the largest municipal settlements in the nation, the result of years of litigation against drug manufacturers and distributors whose marketing practices and distribution oversight failures contributed to the epidemic that has devastated Maryland's largest city. Unlike some jurisdictions that have diverted settlement dollars to general budget purposes or unrelated capital projects, Baltimore passed legislation mandating that these funds address harm reduction, education, and systemic factors driving substance use.

To date, the city has allocated $122 million of the total settlement, with more than $13 million already spent on specific programs and services. The dashboard breaks down these investments by category, showing how funds flow to city agencies, community-based organizations, and direct service providers working in neighborhoods hardest hit by overdose deaths.

The transparency framework emerged from an executive order Scott issued in August 2024, which established the Opioid Restitution Fund and created the Baltimore City Mayor's Office of Overdose Response (BCMOOR) to oversee strategic deployment. An accompanying Restitution Advisory Board, composed of public health experts, community advocates, and individuals with lived experience of addiction, provides ongoing input on funding priorities.

What the Dashboard Reveals

The online tool offers granular visibility into settlement spending that few other cities have attempted. Users can explore investments by organization, program type, and geographic distribution across Baltimore's neighborhoods. Each funded project includes descriptions of services provided, alignment with approved use categories, total amounts committed, and actual spending to date.

February's first round of community grants illustrates the approach. The city awarded $2 million to eleven organizations, with individual grants ranging from $50,000 to $500,000. Recipients included an urban farm in Station North providing trauma-informed care and round-the-clock support, a job training program in Curtis Bay specifically targeting women in recovery, and wraparound services connecting families to housing and mental health support for children with parents struggling with addiction.

These investments reflect a philosophy that treats the opioid crisis as requiring responses beyond traditional healthcare settings. By funding urban agriculture, workforce development, and family support services alongside more conventional treatment and harm reduction programs, Baltimore acknowledges that addiction intersects with housing instability, economic marginalization, and intergenerational trauma.

A Model for Accountability

Baltimore's transparency initiative arrives as scrutiny intensifies over how state and local governments nationwide are handling opioid settlement dollars. Investigations by NPR and other outlets have documented instances where jurisdictions diverted settlement funds to fill budget gaps, purchase police vehicles, or support unrelated priorities rather than addressing the addiction crisis the litigation was designed to ameliorate.

The city's approach offers a counterexample. By creating legal requirements for how funds must be spent and then building public infrastructure to track compliance, Baltimore has made it difficult for future administrations to redirect resources without public awareness. The quarterly dashboard updates and annual reporting requirements create accountability mechanisms that extend beyond any single political cycle.

The FY25 Annual Report, covering July 2024 through June 2025, provides additional context beyond the raw financial data. It includes progress updates on executive order implementation, monitoring and oversight mechanisms for grant awards, and preliminary outcome indicators where available. Future dashboard iterations will incorporate organization-specific performance measures, allowing residents to assess not just where money goes but what results it achieves.

The Scale of Baltimore's Crisis

Understanding why $600 million matters requires grasping the severity of Baltimore's overdose epidemic. Maryland has consistently ranked among states with the highest per-capita overdose mortality, and Baltimore City bears a disproportionate share of those deaths. Fentanyl and other synthetic opioids have transformed the crisis in recent years, making overdose reversal more difficult and mortality more unpredictable.

The settlement funds arrive at a moment when Baltimore has seen some encouraging trends. City health department data shows overdose deaths declining in certain populations and neighborhoods, though disparities remain stark. Black residents continue experiencing higher mortality rates than white residents, and certain zip codes face overdose death rates several times the city average.

Harm reduction services—including naloxone distribution, fentanyl test strips, and syringe access programs—have expanded significantly in recent years, contributing to the mortality decline. The settlement dollars enable further scaling of these evidence-based interventions while adding new capacity in areas like recovery housing, peer support services, and treatment for co-occurring mental health conditions.

Challenges Ahead

Despite the transparency achievements, significant challenges remain in translating settlement dollars into measurable mortality reductions. Baltimore, like other cities, faces workforce shortages in addiction medicine and behavioral health. Simply funding services does not guarantee that qualified providers exist to deliver them, particularly in specialized areas like medication-assisted treatment for opioid use disorder.

Geographic distribution of services presents another hurdle. While the dashboard shows where money flows, ensuring equitable access across Baltimore's diverse neighborhoods requires ongoing attention. East and West Baltimore, areas with historically high overdose rates, need sustained investment to overcome decades of disinvestment in healthcare infrastructure.

The eighteen-year payment schedule for settlement funds—typical of national opioid litigation agreements—creates both opportunity and risk. The extended timeline allows for multi-year programming and sustainable system building rather than one-time expenditures. However, it also requires discipline to maintain focus across political transitions and economic cycles that might create pressure to divert funds to immediate crises.

National Implications

Baltimore's dashboard arrives as the broader national conversation about opioid settlement accountability intensifies. With over $50 billion flowing to state and local governments from various pharmaceutical litigation settlements, advocates have pressed for transparency mechanisms that ensure these funds address the crisis they were meant to solve.

The city's approach demonstrates that such transparency is technically feasible and politically achievable. The dashboard was built using relatively modest resources—federal grant funding supported its development—suggesting that other jurisdictions could replicate the model without massive technology investments.

Whether Baltimore's accountability framework influences other cities will depend partly on whether its investments produce measurable results. If the funded programs contribute to sustained overdose mortality declines and improved quality of life for residents in recovery, the transparency model becomes more compelling for other jurisdictions to adopt. Conversely, if outcomes disappoint, critics may argue that transparency matters less than execution.

For now, Baltimore residents can visit the dashboard and see exactly how their city is deploying resources extracted from companies that profited from the addiction crisis. In an era of widespread public skepticism about government spending, that visibility represents a meaningful step toward rebuilding trust—and potentially toward saving lives.